Index RUT
P/E -
EPS (ttm) -4.85
Insider Own 1.63%
Shs Outstand 30.95M
Perf Week -11.43%
Market Cap 2.31B
Forward P/E -
EPS next Y -2.00
Insider Trans -3.28%
Shs Float 30.79M
Perf Month -0.62%
Income -150.66M
PEG -
EPS next Q -0.37
Inst Own 113.56%
Short Float 8.90%
Perf Quarter 5.56%
Sales 560.02M
P/S 4.13
EPS this Y 7.22%
Inst Trans 10.07%
Short Ratio 4.74
Perf Half Y -16.06%
Book/sh 2.29
P/B 32.22
EPS next Y 46.75%
ROA -22.33%
Short Interest 2.74M
Perf Year -11.23%
Cash/sh 16.68
P/C 4.43
EPS next 5Y -
ROE -103.34%
52W Range 55.92 - 124.11
Perf YTD -30.96%
Dividend Est. -
P/FCF -
EPS past 5Y -13.90%
ROI -19.03%
52W High -40.46%
Beta 1.22
Dividend TTM -
Quick Ratio 6.12
Sales past 5Y 27.64%
Gross Margin 67.83%
52W Low 32.15%
ATR (14) 3.91
Dividend Ex-Date -
Current Ratio 6.27
EPS Y/Y TTM -40.62%
Oper. Margin -19.07%
RSI (14) 43.84
Volatility 4.19% 5.27%
Employees 2000
Debt/Eq 10.25
Sales Y/Y TTM 18.45%
Profit Margin -26.90%
Recom 1.25
Target Price 98.27
Option/Short Yes / Yes
LT Debt/Eq 10.03
EPS Q/Q -66.76%
Payout -
Rel Volume 0.81
Prev Close 73.74
Sales Surprise 0.37%
EPS Surprise -86.23%
Sales Q/Q 18.41%
Earnings Oct 30 AMC
Avg Volume 578.24K
Price 73.90
SMA20 -8.32%
SMA50 1.50%
SMA200 -18.86%
Trades
Volume 469,923
Change 0.22%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-04-24 Initiated
Goldman
Neutral
$78
Jun-20-24 Upgrade
Wolfe Research
Peer Perform → Outperform
$115
Dec-11-23 Upgrade
Citigroup
Neutral → Buy
$110
Jul-19-23 Initiated
Robert W. Baird
Outperform
$130
Feb-07-23 Initiated
Wells Fargo
Overweight
$150
Nov-07-22 Upgrade
Wolfe Research
Underperform → Peer Perform
Jun-09-22 Downgrade
Citigroup
Buy → Neutral
$180 → $155
Apr-06-22 Initiated
Wolfe Research
Underperform
$105
Feb-24-22 Upgrade
Needham
Hold → Buy
$135
Feb-24-22 Upgrade
Needham
Hold → Buy
Jan-18-22 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$129 → $167
Jan-12-22 Upgrade
BTIG Research
Neutral → Buy
$170
Jan-11-22 Upgrade
Oppenheimer
Perform → Outperform
$150
Dec-21-21 Resumed
Canaccord Genuity
Buy
$125
Dec-17-21 Upgrade
JP Morgan
Neutral → Overweight
$100 → $116
Dec-15-21 Upgrade
Citigroup
Neutral → Buy
$120
Jun-02-21 Downgrade
Citigroup
Buy → Neutral
$105 → $78
Apr-13-21 Downgrade
BTIG Research
Buy → Neutral
Apr-12-21 Downgrade
JP Morgan
Overweight → Neutral
Feb-26-21 Downgrade
Colliers Securities
Buy → Neutral
Show Previous Ratings
Nov-20-24 04:30PM
Nov-18-24 10:00AM
08:15AM
Nov-05-24 04:30PM
Nov-01-24 08:49AM
07:45AM
Loading…
07:45AM
Oct-31-24 03:16AM
Oct-30-24 06:35PM
05:15PM
04:08PM
Oct-28-24 08:02AM
Oct-23-24 07:47AM
06:00AM
Oct-22-24 01:18PM
12:24PM
08:56AM
Loading…
08:56AM
07:36AM
Oct-21-24 04:05PM
Oct-16-24 04:05PM
07:57AM
Oct-11-24 06:57AM
Oct-04-24 04:45AM
Sep-12-24 04:32AM
Sep-11-24 08:05AM
Sep-09-24 08:05AM
Sep-04-24 07:30AM
02:00AM
Sep-01-24 01:33PM
Aug-29-24 08:00AM
Aug-21-24 04:05PM
12:00PM
Loading…
Aug-07-24 12:00PM
Aug-02-24 12:15AM
Aug-01-24 06:15PM
04:06PM
04:05PM
Jul-22-24 11:00AM
Jul-21-24 10:00AM
Jul-18-24 04:05PM
Jul-14-24 09:15AM
Jun-28-24 07:28PM
Jun-23-24 12:19AM
Jun-17-24 04:05PM
Jun-05-24 03:00PM
Jun-04-24 04:05PM
May-22-24 04:05PM
May-05-24 08:36AM
May-03-24 10:05AM
07:05AM
(Thomson Reuters StreetEvents)
May-02-24 10:54PM
05:39PM
04:05PM
09:45AM
Apr-23-24 12:35PM
Apr-18-24 04:05PM
Apr-08-24 04:09AM
Apr-01-24 05:45AM
Mar-20-24 05:45AM
Mar-13-24 11:30AM
Mar-08-24 04:30PM
Mar-05-24 11:29PM
Mar-04-24 11:42PM
06:45AM
Feb-29-24 04:30PM
Feb-23-24 12:30PM
11:06AM
05:45AM
Feb-22-24 05:50PM
04:36PM
04:05PM
Feb-20-24 01:59PM
05:45AM
Feb-08-24 04:05PM
Jan-14-24 12:54PM
Jan-08-24 08:30AM
Jan-05-24 08:05AM
Jan-04-24 07:01PM
Jan-03-24 08:00AM
Dec-26-23 04:30PM
Nov-13-23 08:05AM
Nov-03-23 10:41AM
09:44AM
(Thomson Reuters StreetEvents)
Nov-02-23 06:22PM
04:05PM
Oct-31-23 10:01AM
Oct-27-23 09:35AM
Oct-26-23 10:02AM
Oct-19-23 04:05PM
Sep-28-23 08:23AM
Sep-27-23 07:35PM
Sep-26-23 08:05AM
Sep-22-23 11:47AM
Aug-29-23 08:30AM
Aug-23-23 06:00AM
Aug-04-23 10:45AM
(Simply Wall St.) +18.26%
Aug-03-23 05:55PM
04:10PM
04:05PM
Jul-26-23 04:24PM
(The Wall Street Journal)
Jul-20-23 04:05PM
Jul-18-23 08:30AM
iRhythm Technologies, Inc. is a digital healthcare company, which engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
TALWALKAR ABHIJIT Y Director Nov 04 '24 Buy 75.16 6,664 500,866 18,941 Nov 05 11:59 AM Blackford Quentin S. President and CEO Nov 04 '24 Sale 77.41 16,145 1,249,784 159,929 Nov 05 11:59 AM Bobzien Brice Chief Financial Officer Aug 09 '24 Sale 70.34 1,372 96,506 24,428 Aug 12 08:24 PM Patterson Chad Chief Commercial Officer May 31 '24 Buy 74.98 280 20,994 40,145 Aug 05 05:35 PM Patterson Chad Chief Commercial Officer Aug 02 '24 Sale 74.66 3,012 224,876 37,133 Aug 05 05:35 PM Smith Mervin EVP Strategic Business Ops Aug 02 '24 Sale 74.66 688 51,366 10,360 Aug 05 05:35 PM Turakhia Minang EVP, CMO & CSO Jul 02 '24 Sale 105.65 1,404 148,333 27,255 Jul 03 03:35 PM Rosenbaum Marc W. Chief Accounting Officer Jun 03 '24 Sale 88.91 510 45,344 8,174 Jun 05 12:40 PM Shrishrimal Sumi EVP, Chief Risk Officer Jun 03 '24 Sale 88.91 1,131 100,557 23,298 Jun 05 12:40 PM Day Mark J. Chief Technology Officer Mar 04 '24 Sale 111.14 3,248 360,983 61,164 Mar 05 04:53 PM Patterson Chad Chief Commercial Officer Mar 04 '24 Sale 111.14 1,077 119,698 39,865 Mar 05 04:52 PM Blackford Quentin S. President and CEO Mar 04 '24 Sale 111.14 4,221 469,122 175,794 Mar 05 04:52 PM Turakhia Minang EVP, CMO & CSO Mar 04 '24 Sale 111.14 943 104,805 28,659 Mar 05 04:50 PM Wilson Daniel G. EVP, Corp Dev Inv Rel Mar 04 '24 Sale 111.14 2,452 272,515 30,515 Mar 05 04:50 PM Bobzien Brice Chief Financial Officer Mar 04 '24 Sale 111.14 1,401 155,707 25,800 Mar 05 04:50 PM Shrishrimal Sumi EVP, Chief Risk Officer Mar 04 '24 Sale 111.14 723 80,354 24,429 Mar 05 04:49 PM Murphy Patrick Michael CBO and CLO Feb 29 '24 Sale 121.96 7,615 928,725 48,962 Mar 01 07:19 PM Blackford Quentin S. President and CEO Feb 29 '24 Sale 121.96 24,701 3,012,534 180,015 Mar 01 07:19 PM Day Mark J. Chief Technology Officer Feb 29 '24 Sale 121.96 1,475 179,891 64,412 Mar 01 07:18 PM Wilson Daniel G. EVP, Corp Dev Inv Rel Feb 29 '24 Sale 121.96 1,261 153,792 32,967 Mar 01 07:18 PM Wilson Daniel G. EVP, Corp Dev Inv Rel Jan 02 '24 Sale 103.31 7,218 745,692 26,629 Jan 04 11:57 AM
Index RUT
P/E -
EPS (ttm) -1.27
Insider Own 29.48%
Shs Outstand 139.25M
Perf Week 16.95%
Market Cap 1.45B
Forward P/E -
EPS next Y -0.11
Insider Trans 0.34%
Shs Float 99.97M
Perf Month 99.03%
Income -177.87M
PEG -
EPS next Q -0.05
Inst Own 58.79%
Short Float 11.81%
Perf Quarter 77.87%
Sales 572.74M
P/S 2.53
EPS this Y 15.60%
Inst Trans -2.73%
Short Ratio 4.98
Perf Half Y 1.09%
Book/sh -0.01
P/B -
EPS next Y 74.75%
ROA -25.12%
Short Interest 11.81M
Perf Year -10.91%
Cash/sh 0.57
P/C 17.87
EPS next 5Y 12.00%
ROE -21137.14%
52W Range 4.88 - 17.34
Perf YTD -32.43%
Dividend Est. -
P/FCF -
EPS past 5Y -5.07%
ROI -30.81%
52W High -41.12%
Beta 1.35
Dividend TTM -
Quick Ratio 1.15
Sales past 5Y 40.20%
Gross Margin 56.47%
52W Low 109.22%
ATR (14) 0.55
Dividend Ex-Date -
Current Ratio 2.32
EPS Y/Y TTM 15.65%
Oper. Margin -23.93%
RSI (14) 73.90
Volatility 7.47% 6.99%
Employees 839
Debt/Eq 25.35
Sales Y/Y TTM 27.21%
Profit Margin -31.06%
Recom 1.25
Target Price 16.83
Option/Short Yes / Yes
LT Debt/Eq 24.96
EPS Q/Q 20.73%
Payout -
Rel Volume 0.69
Prev Close 9.93
Sales Surprise 2.40%
EPS Surprise -1.22%
Sales Q/Q 27.44%
Earnings Oct 30 AMC
Avg Volume 2.37M
Price 10.21
SMA20 23.43%
SMA50 54.24%
SMA200 2.76%
Trades
Volume 1,639,013
Change 2.82%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-01-24 Downgrade
Morgan Stanley
Overweight → Equal-Weight
Jul-08-24 Initiated
Barclays
Overweight
$19
Feb-09-24 Initiated
Wells Fargo
Overweight
$26
Dec-19-23 Reiterated
Needham
Buy
$16 → $18
Oct-20-23 Initiated
ROTH MKM
Buy
$22
Oct-12-22 Initiated
Jefferies
Buy
$12
Sep-12-22 Initiated
Morgan Stanley
Overweight
$13
Dec-03-21 Initiated
Goldman
Neutral
$12.50
Oct-29-21 Initiated
Loop Capital
Buy
$22
Aug-25-21 Initiated
Needham
Buy
$18
Aug-04-21 Resumed
Cowen
Outperform
$22.50
Mar-05-21 Reiterated
H.C. Wainwright
Buy
$16 → $19
Dec-21-20 Reiterated
H.C. Wainwright
Buy
$12 → $16
Oct-20-20 Initiated
Stifel
Buy
$13
Sep-03-20 Initiated
Cowen
Outperform
$12
Jun-18-20 Initiated
Northland Capital
Outperform
$9
Aug-28-19 Initiated
Canaccord Genuity
Buy
$7
Aug-05-19 Initiated
Piper Jaffray
Overweight
$7
Oct-16-17 Initiated
Lake Street
Buy
$7
Aug-14-17 Initiated
H.C. Wainwright
Buy
$4
Show Previous Ratings
Nov-20-24 04:40AM
Nov-04-24 09:00AM
Oct-31-24 03:20AM
Oct-30-24 05:10PM
04:06PM
(Associated Press Finance)
04:00PM
Loading…
04:00PM
Oct-07-24 09:00AM
Sep-18-24 09:00AM
Aug-22-24 01:01AM
Aug-05-24 05:01PM
05:01PM
Jul-31-24 05:15PM
04:09PM
(Associated Press Finance)
04:00PM
Jul-29-24 09:00AM
09:00AM
Loading…
Jul-24-24 09:00AM
Jul-10-24 09:00AM
Jun-10-24 09:00AM
May-08-24 01:07PM
May-07-24 09:56PM
06:00PM
04:43PM
(Associated Press Finance)
04:00PM
May-02-24 09:00AM
Apr-26-24 07:00PM
04:41PM
Apr-17-24 09:00AM
Mar-10-24 03:24PM
Mar-08-24 11:54PM
Mar-04-24 11:52PM
12:40AM
Loading…
Mar-01-24 12:40AM
Feb-28-24 10:14AM
Feb-27-24 04:58PM
04:52PM
(Associated Press Finance)
04:01PM
Jan-29-24 09:00AM
Jan-08-24 09:00AM
08:00AM
Dec-19-23 09:00AM
Nov-07-23 10:52AM
Nov-06-23 04:43PM
04:39PM
(Associated Press Finance)
04:05PM
Nov-01-23 09:00AM
Oct-31-23 09:00AM
Oct-27-23 04:05PM
Oct-25-23 05:38PM
Oct-24-23 10:59PM
04:01PM
Oct-23-23 07:00AM
Oct-17-23 04:05PM
09:00AM
Oct-16-23 04:05PM
09:00AM
Oct-09-23 04:05PM
Oct-05-23 12:37PM
Sep-18-23 12:14PM
Sep-14-23 01:12PM
Sep-08-23 07:36PM
01:05PM
Aug-07-23 11:00AM
Aug-03-23 04:11PM
04:00PM
Jul-24-23 09:00AM
Jul-18-23 09:00AM
Jul-02-23 09:37AM
Jun-27-23 04:16PM
(Investor's Business Daily)
Jun-06-23 07:00AM
Jun-04-23 10:47AM
May-23-23 09:00AM
May-04-23 04:53PM
04:05PM
10:42AM
Apr-19-23 05:00PM
04:07PM
04:05PM
Apr-17-23 08:24AM
Apr-13-23 09:00AM
Apr-04-23 09:00AM
Mar-13-23 09:39AM
Mar-03-23 08:10PM
Feb-28-23 07:25PM
04:05PM
Feb-21-23 09:00AM
Feb-10-23 08:40AM
Feb-07-23 09:00AM
Jan-09-23 09:00AM
Jan-08-23 09:10AM
Dec-28-22 09:00AM
Dec-12-22 12:32PM
Nov-09-22 06:22AM
Nov-03-22 06:45PM
04:05PM
06:36AM
Nov-01-22 10:01AM
09:00AM
Oct-27-22 10:02AM
Oct-17-22 12:41PM
Oct-12-22 09:00AM
Oct-11-22 09:00AM
Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
PATRICK MILES Director Nov 20 '24 Proposed Sale 9.57 100,000 957,000 Nov 20 04:33 PM Bakst Evan Director Aug 23 '24 Buy 5.76 35,000 201,600 50,000 Aug 26 04:32 PM Pelizzon David R Director Aug 23 '24 Buy 5.89 16,978 100,000 331,696 Aug 26 04:27 PM Pelizzon David R Director Aug 22 '24 Buy 5.67 8,818 49,998 314,718 Aug 26 04:27 PM Demski David M Director Aug 21 '24 Buy 5.67 50,000 283,500 288,441 Aug 21 10:00 PM Lish Scott CHIEF OPERATING OFFICER Aug 06 '24 Option Exercise 2.80 71,500 199,925 580,861 Aug 08 05:29 PM Demski David M Director Aug 02 '24 Buy 6.56 40,000 262,400 238,441 Aug 05 02:49 PM Valentine Keith Director Aug 02 '24 Buy 6.55 39,000 255,450 82,140 Aug 05 02:48 PM Marshall Tyson Eliot GENERAL COUNSEL & CORP. SEC. Jun 12 '24 Sale 10.88 50,232 546,524 245,638 Jun 14 04:30 PM Koning John Todd CHIEF FINANCIAL OFFICER Apr 24 '24 Sale 12.82 37,500 480,750 393,356 Apr 26 04:38 PM Bakst Evan Director Mar 14 '24 Buy 13.53 15,000 202,950 15,000 Mar 18 11:35 AM Blackford Quentin S. Director Mar 07 '24 Buy 12.83 20,000 256,600 572,605 Mar 08 08:55 PM Marshall Tyson Eliot GENERAL COUNSEL & CORP. SEC. Mar 06 '24 Sale 13.16 9,225 121,401 295,870 Mar 08 05:30 PM Marshall Tyson Eliot GENERAL COUNSEL & CORP. SEC. Mar 01 '24 Sale 13.30 11,825 157,272 305,095 Mar 04 08:45 PM Koning John Todd CHIEF FINANCIAL OFFICER Mar 01 '24 Sale 13.30 121,601 1,617,293 430,856 Mar 04 08:43 PM Sponsel David EVP, SALES Feb 27 '24 Sale 15.19 32,365 491,624 622,296 Feb 29 06:51 PM Lish Scott CHIEF OPERATING OFFICER Feb 27 '24 Sale 15.19 31,075 472,029 507,165 Feb 29 06:49 PM Hunsaker Craig E EVP, PEOPLE & CULTURE Feb 26 '24 Sale 15.05 41,560 625,478 1,188,444 Feb 28 12:21 PM Sponsel David EVP, SALES Feb 21 '24 Sale 15.34 17,820 273,359 654,661 Feb 22 06:31 PM Hunsaker Craig E EVP, PEOPLE & CULTURE Feb 20 '24 Sale 15.16 77,255 1,171,186 1,188,814 Feb 22 06:31 PM Lish Scott CHIEF OPERATING OFFICER Feb 21 '24 Sale 15.34 11,963 183,512 538,240 Feb 22 06:30 PM Sponsel David EVP, SALES Feb 14 '24 Sale 16.16 2,500 40,400 637,418 Feb 15 05:49 PM Sponsel David EVP, SALES Feb 02 '24 Sale 16.47 36,620 603,131 639,918 Feb 05 06:48 PM Hunsaker Craig E EVP, PEOPLE & CULTURE Feb 02 '24 Sale 16.51 38,556 636,560 1,266,569 Feb 05 06:46 PM Hunsaker Craig E EVP, PEOPLE & CULTURE Feb 05 '24 Sale 16.41 500 8,205 1,266,069 Feb 05 06:46 PM Lish Scott CHIEF OPERATING OFFICER Feb 02 '24 Sale 16.47 25,210 415,209 518,457 Feb 05 06:44 PM Sponsel David EVP, SALES Jan 16 '24 Sale 15.00 2,500 37,500 555,280 Jan 17 04:30 PM Sponsel David EVP, SALES Dec 21 '23 Sale 15.00 2,500 37,500 557,780 Dec 26 07:25 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite